论文信息 - gastrointestinal tumours, colorectalNintedanib plus best supportive care (BSC) versus placebo plus BSC for the treatment of patients (pts) with colorectal cancer (CRC) refractory to standard therapies: Results of the phase III LUME-colon 1 study - 字舞流文

gastrointestinal tumours, colorectalNintedanib plus best supportive care (BSC) versus placebo plus BSC for the treatment of patients (pts) with colorectal cancer (CRC) refractory to standard therapies: Results of the phase III LUME-colon 1 study

H. Lenz | J. Tabernero | F. Ciardiello | E. Maiello | A. Falcone | T. Yoshino | S. Lonardi | A. Sobrero | E. Cutsem | J. Tomasek | Y. Hong | M. Saunders | M. Studeny | H. Taniguchi | M. Limón | Y. Park | J. Hocke | Z. Oum'hamed | S. Vlassak | R. F. Monteagudo